V Sangrigoli

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
BACKGROUND Venous thromboembolic disease is a recurring reason for death, it is often well-known but sometimes misunderstood. The right treatment for this pathology should not follow one approach only, but several strategies with respect to the seriousness and extension of the several clinical pictures. In particular the pharmacological therapy tries to(More)
Fifty-eight patients with acute and chronic pathology of the lower limbs were treated with daily oral doses of 96 mg of mesoglycan, a drug having antithrombotic and fibrinolytic properties. After a 3-months trial both clinical picture and instrumental parameters were found to be improved.
  • 1